147 related articles for article (PubMed ID: 27567948)
1. Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma Cells.
Waters AM; Stafman LL; Garner EF; Mruthyunjayappa S; Stewart JE; Mroczek-Musulman E; Beierle EA
Transl Oncol; 2016 Aug; 9(4):263-73. PubMed ID: 27567948
[TBL] [Abstract][Full Text] [Related]
2. FAK Inhibition Decreases Hepatoblastoma Survival Both In Vitro and In Vivo.
Gillory LA; Stewart JE; Megison ML; Nabers HC; Mroczek-Musulman E; Beierle EA
Transl Oncol; 2013 Apr; 6(2):206-15. PubMed ID: 23544173
[TBL] [Abstract][Full Text] [Related]
3. FAK inhibition abrogates the malignant phenotype in aggressive pediatric renal tumors.
Megison ML; Gillory LA; Stewart JE; Nabers HC; Mrozcek-Musulman E; Beierle EA
Mol Cancer Res; 2014 Apr; 12(4):514-26. PubMed ID: 24464916
[TBL] [Abstract][Full Text] [Related]
4. Focal adhesion kinase (FAK) phosphorylation is a key regulator of embryonal rhabdomyosarcoma (ERMS) cell viability and migration.
Al-Ghabkari A; Qasrawi DO; Alshehri M; Narendran A
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1461-1469. PubMed ID: 31006845
[TBL] [Abstract][Full Text] [Related]
5. FAK Signaling in Rhabdomyosarcoma.
Perrone C; Pomella S; Cassandri M; Braghini MR; Pezzella M; Locatelli F; Rota R
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182556
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma.
Stewart JE; Ma X; Megison M; Nabers H; Cance WG; Kurenova EV; Beierle EA
Mol Carcinog; 2015 Jan; 54(1):9-23. PubMed ID: 23868727
[TBL] [Abstract][Full Text] [Related]
7. High-throughput tyrosine kinase activity profiling identifies FAK as a candidate therapeutic target in Ewing sarcoma.
Crompton BD; Carlton AL; Thorner AR; Christie AL; Du J; Calicchio ML; Rivera MN; Fleming MD; Kohl NE; Kung AL; Stegmaier K
Cancer Res; 2013 May; 73(9):2873-83. PubMed ID: 23536552
[TBL] [Abstract][Full Text] [Related]
8. Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival.
Gillory LA; Stewart JE; Megison ML; Waters AM; Beierle EA
J Surg Res; 2015 Jun; 196(2):339-49. PubMed ID: 25862488
[TBL] [Abstract][Full Text] [Related]
9. The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumor.
Aye JM; Stafman LL; Williams AP; Garner EF; Stewart JE; Anderson JC; Mruthyunjayappa S; Waldrop MG; Goolsby CD; Markert HR; Quinn C; Marayati R; Mroczek-Musulman E; Willey CD; Yoon KJ; Whelan KF; Beierle EA
Oncotarget; 2019 Sep; 10(53):5534-5548. PubMed ID: 31565187
[TBL] [Abstract][Full Text] [Related]
10. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
11. Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review.
Shanthi E; Krishna MH; Arunesh GM; Venkateswara Reddy K; Sooriya Kumar J; Viswanadhan VN
Expert Opin Ther Pat; 2014 Oct; 24(10):1077-100. PubMed ID: 25113248
[TBL] [Abstract][Full Text] [Related]
12. Focal adhesion kinase promotes the aggressive melanoma phenotype.
Hess AR; Postovit LM; Margaryan NV; Seftor EA; Schneider GB; Seftor RE; Nickoloff BJ; Hendrix MJ
Cancer Res; 2005 Nov; 65(21):9851-60. PubMed ID: 16267008
[TBL] [Abstract][Full Text] [Related]
13. High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma.
Wang S; Hwang EE; Guha R; O'Neill AF; Melong N; Veinotte CJ; Conway Saur A; Wuerthele K; Shen M; McKnight C; Alexe G; Lemieux ME; Wang A; Hughes E; Xu X; Boxer MB; Hall MD; Kung A; Berman JN; Davis MI; Stegmaier K; Crompton BD
Clin Cancer Res; 2019 Jul; 25(14):4552-4566. PubMed ID: 30979745
[TBL] [Abstract][Full Text] [Related]
14. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
[TBL] [Abstract][Full Text] [Related]
15. FAK signaling in human cancer as a target for therapeutics.
Lee BY; Timpson P; Horvath LG; Daly RJ
Pharmacol Ther; 2015 Feb; 146():132-49. PubMed ID: 25316657
[TBL] [Abstract][Full Text] [Related]
16. Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma.
Cinatl J; Cinatl J; Michaelis M; Kabickova H; Kotchetkov R; Vogel JU; Doerr HW; Klingebiel T; Driever PH
Cancer Res; 2003 Apr; 63(7):1508-14. PubMed ID: 12670897
[TBL] [Abstract][Full Text] [Related]
17. Targeting FAK scaffold functions inhibits human renal cell carcinoma growth.
Béraud C; Dormoy V; Danilin S; Lindner V; Béthry A; Hochane M; Coquard C; Barthelmebs M; Jacqmin D; Lang H; Massfelder T
Int J Cancer; 2015 Oct; 137(7):1549-59. PubMed ID: 25809490
[TBL] [Abstract][Full Text] [Related]
18. Focal adhesion kinase and its potential involvement in tumor invasion and metastasis.
Kornberg LJ
Head Neck; 1998 Dec; 20(8):745-52. PubMed ID: 9790298
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase B/AKT and focal adhesion kinase: two close signaling partners in cancer.
Wang S; Basson MD
Anticancer Agents Med Chem; 2011 Dec; 11(10):993-1002. PubMed ID: 22023045
[TBL] [Abstract][Full Text] [Related]
20. Focal adhesion kinase: from biological functions to therapeutic strategies.
Tan X; Yan Y; Song B; Zhu S; Mei Q; Wu K
Exp Hematol Oncol; 2023 Sep; 12(1):83. PubMed ID: 37749625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]